173 related articles for article (PubMed ID: 24299152)
1. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
[TBL] [Abstract][Full Text] [Related]
2. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces.
Bäck J; Lang MH; Elgue G; Kalbitz M; Sanchez J; Ekdahl KN; Nilsson B
Biomaterials; 2009 Dec; 30(34):6573-80. PubMed ID: 19783299
[TBL] [Abstract][Full Text] [Related]
3. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B
J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707
[TBL] [Abstract][Full Text] [Related]
4. Activated human platelets induce factor XIIa-mediated contact activation.
Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
[TBL] [Abstract][Full Text] [Related]
5. Evidence of contact activation in patients suffering from ST-elevation myocardial infarction.
Christensen K; Kozarcanin H; Ekdahl KN; Nilsson B
Thromb Res; 2016 May; 141():158-62. PubMed ID: 27058272
[TBL] [Abstract][Full Text] [Related]
6. Activation of the contact system in patients with a first acute myocardial infarction.
Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
[TBL] [Abstract][Full Text] [Related]
7. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
[TBL] [Abstract][Full Text] [Related]
8. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
9. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal relationship between contact and complement system activation on artificial polymers exposed to whole human blood.
Huang S; Engberg AE; Jonsson N; Sandholm K; Nicholls IA; Mollnes TE; Fromell K; Nilsson B; Ekdahl KN
Biomaterials; 2016 Jan; 77():111-9. PubMed ID: 26584351
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation.
Ekdahl KN; Bengtsson AA; Andersson J; Elgue G; Rönnblom L; Sturfelt G; Nilsson B
Br J Haematol; 2004 Apr; 125(1):74-8. PubMed ID: 15015972
[TBL] [Abstract][Full Text] [Related]
12. Competitive-protein adsorption in contact activation of blood factor XII.
Zhuo R; Siedlecki CA; Vogler EA
Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
[TBL] [Abstract][Full Text] [Related]
13. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
Litvinov RI; Nabiullina RM; Zubairova LD; Shakurova MA; Andrianova IA; Weisel JW
Front Immunol; 2019; 10():1626. PubMed ID: 31379831
[TBL] [Abstract][Full Text] [Related]
14. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
15. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.
Konings J; Govers-Riemslag JW; Philippou H; Mutch NJ; Borissoff JI; Allan P; Mohan S; Tans G; Ten Cate H; Ariëns RA
Blood; 2011 Oct; 118(14):3942-51. PubMed ID: 21828145
[TBL] [Abstract][Full Text] [Related]
16. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
17. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
[TBL] [Abstract][Full Text] [Related]
18. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
[TBL] [Abstract][Full Text] [Related]
19. Ongoing contact activation in patients with hereditary angioedema.
Konings J; Cugno M; Suffritti C; Ten Cate H; Cicardi M; Govers-Riemslag JW
PLoS One; 2013; 8(8):e74043. PubMed ID: 24013493
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
